We may be a step closer to a highly effective mRNA vaccine against HIV, but tests so far reveal that the approach can cause ...

The mRNA COVID vaccine used this past season showed no elevated risk of any of the 29 serious adverse events assessed.

Scientists used a mRNA-based vaccine to reliably trigger antibodies that block HIV infection in people and monkeys ...

Mary Talley Bowden, MD, founder of Americans for Health Freedom, an advocacy group that has lobbied against mRNA shots, ...

An mRNA cancer vaccine triggered strong immune responses and improved treatment outcomes in mice, offering a new approach to treat tumors.

Researchers at Harvard Medical School and Brigham and Women's Hospital designed an ingestible capsule that delivers liquid mRNA to the intestines, producing gene expression and reducing inflammation ...

The experimental mRNA vaccine developed at the University of Florida has shown the ability to supercharge the immune system ...

On July 30, DXVX announced that it has entered into a co-development and license agreement valued at approximately USD 220 million with a U.S.-based biotech company for its mRNA-based cancer vaccine.

Biotechnology company Moderna (NASDAQ:MRNA) will be reporting results this Friday before the bell. Here’s what to expect.

Compared to the standard shot, the mRNA vaccine had an overall vaccine efficacy that was 26.6 percent higher, and 27.4 ...

Researchers have developed an optogenetics platform that enables precise spatiotemporal control over the storage and release ...